GRI
Price
$0.99
Change
-$0.05 (-4.81%)
Updated
Nov 5, 04:00 PM (EDT)
SNSE
Price
$0.50
Change
-$0.02 (-3.85%)
Updated
Nov 5, 04:00 PM (EDT)
Earnings call today
Ad is loading...

GRI vs SNSE

Header iconGRI vs SNSE Comparison
Open Charts GRI vs SNSEBanner chart's image
GRI Bio
Price$0.99
Change-$0.05 (-4.81%)
Volume$177.07K
CapitalizationN/A
Sensei Biotherapeutics
Price$0.50
Change-$0.02 (-3.85%)
Volume$25.6K
CapitalizationN/A
View a ticker or compare two or three
GRI vs SNSE Comparison Chart
Loading...
GRI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GRI vs. SNSE commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRI is a StrongBuy and SNSE is a Hold.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (GRI: $1.04 vs. SNSE: $0.52)
Brand notoriety: GRI and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRI: 66% vs. SNSE: 56%
Market capitalization -- GRI: $3.65M vs. SNSE: $12.59M
GRI [@Biotechnology] is valued at $3.65M. SNSE’s [@Biotechnology] market capitalization is $12.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRI’s FA Score shows that 2 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • GRI’s FA Score: 2 green, 3 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, GRI is a better buy in the long-term than SNSE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRI’s TA Score shows that 5 TA indicator(s) are bullish while SNSE’s TA Score has 3 bullish TA indicator(s).

  • GRI’s TA Score: 5 bullish, 4 bearish.
  • SNSE’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, GRI is a better buy in the short-term than SNSE.

Price Growth

GRI (@Biotechnology) experienced а +53.80% price change this week, while SNSE (@Biotechnology) price change was -12.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.79%. For the same industry, the average monthly price growth was +15.00%, and the average quarterly price growth was +10.61%.

Reported Earning Dates

GRI is expected to report earnings on May 10, 2023.

SNSE is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNSE($13.1M) has a higher market cap than GRI($4.06M). SNSE YTD gains are higher at: -24.928 vs. GRI (-97.031). GRI has higher annual earnings (EBITDA): -8.3M vs. SNSE (-28.24M). SNSE has more cash in the bank: 52.3M vs. GRI (6.35M). GRI has less debt than SNSE: GRI (141K) vs SNSE (5.05M). GRI (0) and SNSE (0) have equivalent revenues.
GRISNSEGRI / SNSE
Capitalization4.06M13.1M31%
EBITDA-8.3M-28.24M29%
Gain YTD-97.031-24.928389%
P/E Ratio0.02N/A-
Revenue00-
Total Cash6.35M52.3M12%
Total Debt141K5.05M3%
FUNDAMENTALS RATINGS
GRI: Fundamental Ratings
GRI
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRISNSE
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 2 days ago
73%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
GRI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NPWR8.860.35
+4.11%
NET Power
DMAC4.420.17
+4.00%
DiaMedica Therapeutics
UAA8.640.12
+1.41%
Under Armour
AVTR22.550.24
+1.08%
Avantor
OTRK1.77-0.08
-4.32%
Ontrak Inc

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
-5.45%
IDYA - GRI
54%
Loosely correlated
+4.90%
NLSP - GRI
38%
Loosely correlated
+21.94%
GOVX - GRI
37%
Loosely correlated
-6.25%
SNSE - GRI
34%
Loosely correlated
+6.00%
GNPX - GRI
34%
Loosely correlated
-6.05%
More

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+6.00%
VSTM - SNSE
50%
Loosely correlated
-0.51%
ALZN - SNSE
40%
Loosely correlated
+0.30%
FATE - SNSE
36%
Loosely correlated
+13.58%
GRI - SNSE
34%
Loosely correlated
-5.45%
GOSS - SNSE
34%
Loosely correlated
+1.44%
More